Integra LifeSciences (IART) Reports In-Line Q3 EPS, Revenues Miss; Raises FY18 Revenue Outlook, Maintains FY18 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Integra LifeSciences Holdings (NASDAQ: IART) | Delayed: 12.03 -0.29 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.32 | 52 Week High | $88.86 | |||
| Open | $12.12 | 52 Week Low | $54.75 | |||
| Day High | $12.40 | P/E | N/A | |||
| Day Low | $11.87 | EPS | $-0.59 | |||
| Volume | 293,821 | |||||
